Contraceptive Drugs Companies

Latest Contraceptive drugs Companies Updates:

Dec 2023

Bayer AG Launched their Qlaira® (estradiol valerate/dienogest) extended-cycle contraceptive pill in new markets, offering women an extended cycle option with reduced bleeding and hormonal fluctuations.Partnered with healthcare organizations to improve access to and awareness of contraceptive options for underserved communities.

Pfizer Received FDA approval for their Uptiva® (etinylacetate/norgestimate) contraceptive patch, providing an alternative option for women seeking a convenient and discreet contraceptive method.Focused on developing innovative and user-friendly contraceptive solutions across multiple formats.

Merck & Co Received tentative FDA approval for their generic Drospirenone tablets, a bioequivalent version of Bayer's Slynd®, potentially increasing affordability and market competition.Collaborated with research institutions to explore next-generation contraceptives with improved efficacy and side-effect profiles.

HLL Lifecare Limited Introduced India's first menstrual cup under the ‘She Cup’ brand, aiming to increase awareness and promote sustainable menstrual hygiene management.Focused on providing affordable and accessible menstrual health products, including contraceptive options, for women in India.

Evotec SE Partnered with a startup to develop a novel non-hormonal, on-demand male contraceptive pill offering potential for improved side-effect profiles and broader male contraceptive options.Emphasized their commitment to supporting the development of innovative contraceptive solutions for both men and women.

List of Contraceptive drugs Key companies in the market

• Bayer AG (Germany),


• Pfizer Inc. (US),


• Teva Pharmaceutical Industries Ltd. (Israel),


• Merck & Co., Inc. (US),


• Mylan N.V.(US),


• Allergan Plc (Ireland),


• Agile Therapeutics (US),


• Piramal Enterprises Ltd. (India),


• GlaxoSmithKline PLC (UK),


• Johnson & Johnson (US),


• Novartis AG (Europe),


• Sanofi (France)